PHARMOS, a.s. made a net profit of CZK 13.6 mil in 2015, up 132% when compared to the previous year. Historically, company's net profit reached an all time high of CZK 16.2 mil in 2011 and an all time low of CZK -27.0 mil in 2012.
This implies return on equity of 2.33% and return on invested capital of 0.974% in 2015. That is compared to 0.518% and 0.228% average seen in the last five years.
Since 2010, net profit of the firm increased by -3.26% or -0.662% a year on average.
As far as PHARMOS, a.s.'s peers are concerned, Geco generated ROE of 63.4% and ROCE of 46.6% in 2015.